After experiencing an irritating cough, Mike had tests that confirmed it was a type of cancer caused by a virus, called HPV 16. Mike underwent surgery to remove the tumour from the back of his tongue, but he was told that, if the cancer was to return, his options would be limited.
Mike was then invited to take part in the HARE-40 trial at the University of Southampton’s Centre for Cancer Immunology. This trial aimed to reduce the likelihood of cancer coming back by testing a new vaccine for cancer.
Mike was the first person in the world to receive the vaccine.
“It was a proud moment, to be the first person to receive the vaccine as I knew I was making a small contribution to a larger fight against cancer. How are we going to get new treatments and move medical research forward if we don’t volunteer for studies?”
Today, Mike has witnessed his granddaughter Sophia (pictured below) grow into a lively seven-year-old. His gratitude for the extra time granted by the vaccine fuels his commitment to life and loved ones.
“I believe that I’m still around today because of the vaccine and all the hard work of the clinicians and teams at Southampton and Poole”.
Unfortunately, Mike faced another hurdle – a small stroke. Quick action by the health service once again saved him. Mike acknowledges the fragility of life but remains optimistic and is planning to participate in another trial and support the university of Southampton as a patient representative.
“I never thought it was a stroke, but I was so lucky. Once again, the health service saved me, and I’ve come out the right side. The past nine years has given me a new appreciation for life. I know that my cancer could come back, or I could be struck with something else, like the stroke, so I try and make the best of the time I have and make good decisions for my family”.
Mike is just one of the many amazing patients our researchers and clinicians see, and his experience shows just how important you are to our research.
With the University Hospital Southampton as part of the University’s campus footprint and stone’s throw away from the Centre for Cancer Immunology, we’re in an excellent position to further medical research because of the access to patients and patient samples. The hospital is one of the UK’s highest recruiting trusts of patients to pioneering clinical trials which test new medicines.
Mike’s story is testament to the power of cancer immunology research and what can be achieved when researchers and clinicians work together. Through your support, you are helping to create a future where success stories like Mike’s become the norm, ensuring more people with cancer live longer, healthier lives.